The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

When HHS Secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...